Finding Relief After Years of Unbearable Pain from Sickle Cell Disease: Allan's Story
Allan Byamukama was one of the first 15 people in the world to receive a cutting-edge gene therapy for sickle cell disease.
Past themes of Annual Workshops (begun in the second year of the CSIBD) include:
Allan Byamukama was one of the first 15 people in the world to receive a cutting-edge gene therapy for sickle cell disease.
Mass General Brigham researchers say both types of artificial intelligence (AI) tools have potential to augment one another to better inform treatment decisions.
Physician-scientists at Massachusetts General Hospital are leading a clinical trial assessing the effectiveness of cell therapy to reinforce weakened tissue associated with fecal incontinence.
Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before having weight loss surgery, suggesting that a surgery first strategy could lead to better outcomes.
Myocarditis is driven by a different immune response than the anti-tumor one, suggesting that the serious complication could one day be managed without halting cancer therapy.
Read how proton therapy saved the life of 19-year-old Chris Kobos after he was diagnosed with a rare chordoma.